Moderate to intense exercise may boost efficacy of leukemia treatment
Recent research suggests that short bouts of moderate to intense exercise could boost the efficacy of a monoclonal antibody drug called rituximab, used to treat chronic lymphocytic leukemia.
Recent research suggests that short bouts of moderate to intense exercise could boost the efficacy of a monoclonal antibody drug called rituximab, used to treat chronic lymphocytic leukemia.
